In the ever-evolving field of genetic testing, the webinar titled “High Quality DNA with Revvity’s chemagic 360 for Genetic Testing” presented by Dr. Karine Auribault, a seasoned expert in molecular genetics and diagnostics, offered valuable insights.

Dr. Karine Auribault, a laboratory manager at George Pompidou European Hospital, has extensive experience in molecular genetics and diagnostics, including a significant contribution to a patent on a tool for diagnosing and treating prostate cancer.

The chemagic 360 instrument was implemented into Dr. Auribault´s laboratory workflow and validated through rigorous testing. The instrument demonstrated high reproducibility and yielded high-quality DNA suitable for various downstream applications such as Next Generation Sequencing (NGS), Multiplex Ligation-dependent Probe Amplification (MLPA), PCR, and Sanger sequencing.

The webinar highlights several downstream applications of the high integrity DNA extracted using the chemagic 360 instrument. These applications ranged from NGS and MLPA to more recent technologies like long-read sequencing and digital PCR. The high-quality DNA obtained from the chemagic 360 instrument proved to be compatible with all these applications, demonstrating the instrument’s versatility.

This webinar shows the significant role that instruments like the chemagic 360 instrument play in advancing the field of genetic workflows The high integrity DNA opens a plethora of possibilities in downstream analysis, contributing to the ongoing evolution of genetic analysis.

For research use only. Not for use in diagnostic procedures.